Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

EMA clears Bayer's Stivarga for liver cancer

EMA clears Bayer's Stivarga for liver cancer Stivarga is a key component among a new generation of pharma products - along with cancer drug Xofigo (radium-223 dichloride), anticoagulant Xarelto (rivaroxaban), ophthalmic therapy Eylea (aflibercept) and pulmonary arterial hypertension

Xarelto and Eylea continue to dominate Bayer's pharma sales

Xarelto and Eylea continue to dominate Bayer's pharma sales Anticoagulant Xarelto (rivaroxaban) led the charge, rising 30% to bring in 2.9bn, with eye treatment Eylea (aflibercept) up 32% with sales of 1.6bn. ... Between them the five products posted sales of 5.4bn in 2016, although Xarelto and Eylea dominated

Promoting off-label use: where to draw the line?

Promoting off-label use: where to draw the line? not address the impact that off-label prescription could have on other innovative players in this clinical field, notably on Regeneron, whose Eylea product is the latest treatment in this area.

Novartis' AMD drug pegpleranib fails phase III programme

Novartis' AMD drug pegpleranib fails phase III programme s Eylea (aflibercept) and off-label use of Roche's Avastin (bevacizumab).

Deal Watch October 2016

Deal Watch October 2016 330. Ocular Therapeutics (US). Regeneron (US). Licence collaboration. Hydrogel sustained release aflibercept (Eylea) for wet macular degeneration.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...

Infographics